| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |